Clinical Trial Update: A Phase 2 Feasibility Study of Abraxane and Carboplatin in Epithelial Neoplasms of the Uterus [Phase 2]

View source ↗

Summary

Phase 2 feasibility study assessing Abraxane (paclitaxel) and carboplatin in epithelial neoplasms of the uterus completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: NYU Langone Health | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2020-03-18